CBX7 and breast carcinoma: Using the integrative approach, we attempt here to delineate the role of aberrant CBX expression in metabolic reprogramming and identify CBX2 and CBX7 (referred as CBX2/7, hereafter) as antagonistic regulators of aerobic glycolysis in breast cancer.